{"DataElement":{"publicId":"2211866","version":"1","preferredName":"Cetuximab Agent Modification Dose Type","preferredDefinition":"the type of cetuximab agent dose modification.","longName":"CETX_AGT_MOD_DOSE_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2211865","version":"1","preferredName":"Cetuximab Agent Modification Dose","preferredDefinition":"information relating to cetuximab agent dose modification.","longName":"CETUXIM_AGT_MOD_DOSE","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2211862","version":"1","preferredName":"Cetuximab Agent","preferredDefinition":"A monoclonal antibody specific for the epidermal growth factor receptor (EGFR), a tyrosine kinase that triggers cell division.  Cetuximab binds to and inhibits EGFRs, which are overexpressed on the cell surfaces of many types of tumors.  This agent blocks the tumor growth, invasion, and metastasis associated with the overexpression of cell-surface EGFRs. (NCI04):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1723:C1708","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Cetuximab","conceptCode":"C1723","definition":"A recombinant, chimeric monoclonal antibody directed against the epidermal growth factor (EGFR) with antineoplastic activity. Cetuximab binds to the extracellular domain of the EGFR, thereby preventing the activation and subsequent dimerization of the receptor; the decrease in receptor activation and dimerization may result in an inhibition in signal transduction and anti-proliferative effects. This agent may inhibit EGFR-dependent primary tumor growth and metastasis. EGFR is overexpressed on the cell surfaces of various solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F38DAD89-EB13-2FE9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2211863","version":"1","preferredName":"Modification Dose","preferredDefinition":"Modification; the act of making something different.:The amount of medicine taken, or radiation given, at one time.","longName":"C25572:C25488","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Modification","conceptCode":"C25572","definition":"Modification; the act of making something different.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F38DAD89-EB18-2FE9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F38DAD89-EB1A-2FE9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2211867","version":"1","preferredName":"Cetuximab Agent Modification Dose Type","preferredDefinition":"the type of cetuximab agent dose modification.","longName":"CETX_AGT_MOD_DOSE_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No dose modification","valueDescription":"No dose modification","ValueMeaning":{"publicId":"2574320","version":"1","preferredName":"No dose modification","longName":"2574320","preferredDefinition":"No dose modification","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF5D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SHIDED","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3EEC825-375F-3CA9-E034-0003BA3F9857","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","deletedIndicator":"No"},{"value":"Dose held","valueDescription":"Dose held","ValueMeaning":{"publicId":"2574321","version":"1","preferredName":"Dose held","longName":"2574321","preferredDefinition":"Dose held","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SHIDED","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3EEC825-3763-3CA9-E034-0003BA3F9857","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","deletedIndicator":"No"},{"value":"Dose reduced","valueDescription":"Dose reduced","ValueMeaning":{"publicId":"2574322","version":"1","preferredName":"Dose reduced","longName":"2574322","preferredDefinition":"Dose reduced","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF5F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SHIDED","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3EEC825-3767-3CA9-E034-0003BA3F9857","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","deletedIndicator":"No"},{"value":"Dose held and reduced","valueDescription":"Dose held and reduced","ValueMeaning":{"publicId":"2574323","version":"1","preferredName":"Dose held and reduced","longName":"2574323","preferredDefinition":"Dose held and reduced","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EF60-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SHIDED","dateModified":"2005-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3EEC825-376B-3CA9-E034-0003BA3F9857","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","deletedIndicator":"No"},{"value":"Drug discontinued","valueDescription":"Drug discontinued","ValueMeaning":{"publicId":"2571809","version":"1","preferredName":"Drug discontinued","longName":"2571809","preferredDefinition":"Drug discontinued","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E58E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CAMPBELB","dateModified":"2004-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F3EEC825-376E-3CA9-E034-0003BA3F9857","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"ONEDATA","dateModified":"2005-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F3EDD739-A7E6-2603-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Cetuximab Dose Modification","type":"Preferred Question Text","description":"Cetuximab Dose Modification","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F3EDD739-A7D2-2603-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-04","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}